Convalescent Plasma for Early Treatment of COVID-19

Clinical trial NCT04390503 · TERMINATED

Trial details

NCT number: NCT04390503
Sponsor: Andrew Eisenberger
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

SARS-CoV 2 COVID-19

Start date: 2021-03-12
Primary completion: 2022-01-06
Enrollment: 223

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.